Two Point Capital Management Inc. Acquires 352 Shares of Amdocs Limited (NASDAQ:DOX)

Two Point Capital Management Inc. raised its holdings in shares of Amdocs Limited (NASDAQ:DOX) by 1.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 34,101 shares of the technology company’s stock after purchasing an additional 352 shares during the quarter. Amdocs accounts for approximately 1.0% of Two Point Capital Management Inc.’s investment portfolio, making the stock its 24th largest holding. Two Point Capital Management Inc.’s holdings in Amdocs were worth $2,922,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Allspring Global Investments Holdings LLC increased its stake in shares of Amdocs by 36.6% during the third quarter. Allspring Global Investments Holdings LLC now owns 3,175,790 shares of the technology company’s stock valued at $277,818,000 after buying an additional 851,022 shares during the period. Pzena Investment Management LLC increased its stake in shares of Amdocs by 12.3% during the third quarter. Pzena Investment Management LLC now owns 6,363,739 shares of the technology company’s stock valued at $556,700,000 after buying an additional 696,136 shares during the period. Hotchkis & Wiley Capital Management LLC increased its stake in shares of Amdocs by 123.2% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 759,136 shares of the technology company’s stock valued at $66,409,000 after buying an additional 419,045 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Amdocs by 1,207.3% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 271,701 shares of the technology company’s stock valued at $23,768,000 after buying an additional 250,918 shares during the period. Finally, Geode Capital Management LLC increased its stake in shares of Amdocs by 10.8% during the third quarter. Geode Capital Management LLC now owns 1,633,733 shares of the technology company’s stock valued at $143,498,000 after buying an additional 158,843 shares during the period. 92.02% of the stock is currently owned by institutional investors.

Amdocs Trading Down 0.4 %

Shares of NASDAQ:DOX opened at $85.96 on Thursday. Amdocs Limited has a 12-month low of $74.41 and a 12-month high of $94.04. The company has a market capitalization of $9.70 billion, a PE ratio of 19.94, a PEG ratio of 1.41 and a beta of 0.71. The business has a 50 day moving average of $85.88 and a two-hundred day moving average of $86.48. The company has a current ratio of 1.16, a quick ratio of 1.20 and a debt-to-equity ratio of 0.22.

Amdocs (NASDAQ:DOX) last announced its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.64 by ($0.19). Amdocs had a net margin of 10.19% and a return on equity of 18.89%. As a group, analysts forecast that Amdocs Limited will post 6.21 EPS for the current year.

Amdocs Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Sunday, April 20th. Shareholders of record on Monday, March 31st will be issued a $0.527 dividend. The ex-dividend date is Monday, March 31st. This is an increase from Amdocs’s previous quarterly dividend of $0.48. This represents a $2.11 dividend on an annualized basis and a yield of 2.45%. Amdocs’s payout ratio is presently 44.55%.

Analyst Upgrades and Downgrades

Several research firms have issued reports on DOX. Oppenheimer lifted their target price on Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a research note on Wednesday, November 13th. Barclays dropped their price target on Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a research note on Thursday, November 14th. Finally, StockNews.com upgraded Amdocs from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, February 5th. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Amdocs currently has a consensus rating of “Buy” and a consensus price target of $101.20.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.